成人生长激素缺乏症死亡率的元分析:生长激素替代疗法真的能提高死亡率吗?
Christa C van Bunderen1, Daniel S Olsson2
1Division of Endocrinology, Department of Internal Medicine, Radboud University Medical Center, Nijmegen 6525 GA, the Netherlands.
Best practice & research. Clinical endocrinology & metabolism
|November 1, 2023
概括
低垂体病患者的生长激素 (GH) 缺乏与较高的死亡率有关. GH替代疗法 (GHRT) 可能会使死亡率正常化,但由于研究偏差,高质量的证据有限.
科学领域:
- 内分泌学 在内分泌学.
- 代谢疾病 代谢疾病
- 临床研究 临床研究
背景情况:
- 增长激素 (GH) 缺乏 (GHD) 是常见的在hypopituitarism.
- 之前的研究表明,在患有GHD的下垂体患者中,死亡风险增加.
- 过度死亡的潜在原因包括潜在的病因,低于最佳的激素替代和治疗副作用.
研究的目的:
- 为了评估GH替代疗法 (GHRT) 是否改善了GHD的成年低位症患者的死亡率.
- 分析现有文献并进行元分析以解决这一临床问题.
主要方法:
- 对调查hypopituitarism和GHD的队列研究进行比较分析.
- 关于GH替代疗法和死亡率的现有研究的元分析.
- 评估潜在的偏见,包括选择和时间相关因素.
主要成果:
- 文献综述和元分析表明,GHT可能有助于使hypopituitarism患者的死亡率正常化.
- 然而,由于现有研究中的大量选择和时间偏差,缺乏高质量的证据.
- 改进的瘤管理和其他激素替代疗法使GHT独立效果的评估变得复杂.
结论:
- 虽然没有通过高质量的证据明确证实,但GHRT似乎在降低GHD下位症患者的过度死亡率方面发挥了作用.
- 需要进一步的严格研究来确定因果关系,并量化GHTR对长期存活的确切影响.
相关概念视频
Comparing the Survival Analysis of Two or More Groups
200
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
200
Bone Disorders
3.6K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.6K
Hypoglycemia and Glucagon
274
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
274
Hormones and Bone Tissue
2.7K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.7K
Hazard Ratio
136
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
136
Nature and Nurture
20.5K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.5K


